DXCM vs GSBD · P/E 63, rev $2.50B vs P/E 14, $997.4M cap
DexCom Inc (DXCM) versus Goldman Sachs BDC Inc (GSBD) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Goldman Sachs BDC Inc (GSBD) is a asset management company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
GSBD does not have a complete income-statement cache yet.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. GSBD currently screens at market cap $997.4M and trailing P/E 13.8.
Not investment advice. Open the DXCM and GSBD stock pages for the full models.
Not investment advice.